Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled
Clinical trial NCT03482180 · COMPLETED
Trial details
- NCT number
- NCT03482180
- Sponsor
- Kuhnil Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-04
- Primary completion
- 2017-05-16
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.